Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.1B
| $18.1M | 0.02% |
178,400
+113,100
| +173% | +$11.4M |
|
|
PDM
877
Piedmont Realty Trust
PDM
$1.19B
| $18.1M | 0.02% |
1,087,100
-1,292,800
| -54% | -$21.6M |
|
878
Extreme Networks
EXTR
$3.2B
| $18.1M | 0.02% |
4,159,446
+599,200
| +17% | +$2.11M |
|
|
OLP
879
One Liberty Properties
OLP
$523M
| $18M | 0.02% |
1,022,936
-85,289
| -8% | -$1.35M |
|
880
EPAM Systems
EPAM
$5.17B
| $18M | 0.02% |
+71,400
| New | +$15.7M |
|
881
FormFactor
FORM
$10.1B
| $18M | 0.02% |
612,569
-591,400
| -49% | -$14.6M |
|
882
Arthur J. Gallagher & Co
AJG
$65.5B
| $17.9M | 0.02% |
184,100
+88,700
| +93% | +$7.85M |
|
883
Werner Enterprises
WERN
$2.31B
| $17.9M | 0.02% |
411,263
+348,170
| +552% | +$14.3M |
|
884
Endava
DAVA
$162M
| $17.8M | 0.02% |
369,075
+33,500
| +10% | +$1.49M |
|
885
Open Text
OTEX
$5.8B
| $17.8M | 0.02% |
418,400
-475,200
| -53% | -$18.8M |
|
886
National Presto Industries
NPK
$998M
| $17.8M | 0.02% |
203,200
+27,500
| +16% | +$2.34M |
|
|
PRSP
887
DELISTED
Perspecta Inc. Common Stock
PRSP
| $17.7M | 0.02% |
762,969
+610,669
| +401% | +$13.3M |
|
888
Liberty Media Series A
FWONA
$23.7B
| $17.7M | 0.02% |
633,613
-67,394
| -10% | -$1.88M |
|
889
CRA International
CRAI
$1.07B
| $17.7M | 0.02% |
447,575
-18,699
| -4% | -$710K |
|
|
ANAT
890
DELISTED
American National Group, Inc. Common Stock
ANAT
| $17.7M | 0.02% |
245,201
+50,600
| +26% | +$3.78M |
|
891
Park Aerospace
PKE
$828M
| $17.7M | 0.02% |
1,585,201
+128,304
| +9% | +$1.59M |
|
|
TGI
892
DELISTED
Triumph Group
TGI
| $17.6M | 0.02% |
1,952,400
+688,548
| +54% | +$5.09M |
|
893
Encompass Health
EHC
$12.3B
| $17.6M | 0.02% |
356,234
+118,787
| +50% | +$6.41M |
|
894
Clean Energy Fuels
CLNE
$384M
| $17.5M | 0.02% |
7,901,332
-1,140,800
| -13% | -$2.3M |
|
895
TransAlta
TAC
$3.92B
| $17.5M | 0.02% |
2,958,141
-544,100
| -16% | -$3.13M |
|
896
W.R. Berkley
WRB
$25.9B
| $17.5M | 0.02% |
688,725
-370,575
| -35% | -$9.09M |
|
897
QCR Holdings
QCRH
$1.73B
| $17.5M | 0.02% |
562,200
-31,000
| -5% | -$893K |
|
|
MRSH
898
Marsh
MRSH
$90.1B
| $17.5M | 0.02% |
+163,000
| New | +$16.5M |
|
899
Ezcorp Inc
EZPW
$1.78B
| $17.5M | 0.02% |
2,777,741
-190,487
| -6% | -$1.03M |
|
|
DSPG
900
DELISTED
DSP Group Inc
DSPG
| $17.5M | 0.02% |
1,102,000
+105,800
| +11% | +$1.73M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.